• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者处理:“ copeptin 检测的效用”。

Approach to the Patient: "Utility of the Copeptin Assay".

机构信息

Department of Endocrinology, Diabetes and Metabolism, University Hospital Basel, 4031 Basel, Switzerland.

Department of Clinical Research, University Hospital Basel, 4031 Basel, Switzerland.

出版信息

J Clin Endocrinol Metab. 2022 May 17;107(6):1727-1738. doi: 10.1210/clinem/dgac070.

DOI:10.1210/clinem/dgac070
PMID:35137148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9113794/
Abstract

Copeptin derives from the same precursor peptide preprovasopressin as arginine vasopressin (AVP). The secretion of both peptides is stimulated by similar physiological processes, such as osmotic stimulation, hypovolemia, or stress. AVP is difficult to measure due to complex preanalytical requirements and due to technical difficulties. In the last years, copeptin was found to be a stable, sensitive, and simple to measure surrogate marker of AVP release. Different immunoassays exist to measure copeptin. The 2 assays which have most often be used in clinical studies are the original sandwich immunoluminometric assay and its automated immunofluorescent successor. In addition, various enzyme-linked immunosorbent assay have been developed. With the availability of the copeptin assay, the differential diagnosis of diabetes insipidus was recently revisited. The goal for this article is therefore to first review the physiology of copeptin, and second to describe its use as marker for the differential diagnosis of vasopressin-dependent fluid disorders, mainly diabetes insipidus but also hyper- and hyponatremia. Furthermore, we highlight the role of copeptin as prognostic marker in other acute and chronic diseases.

摘要

copeptin 源自与精氨酸加压素 (AVP) 相同的前体肽加压素原。这两种肽的分泌都受到类似的生理过程的刺激,如渗透刺激、低血容量或应激。由于分析前的复杂要求和技术困难,AVP 难以测量。在过去的几年中,copeptin 被发现是 AVP 释放的一种稳定、敏感且易于测量的替代标志物。存在多种用于测量 copeptin 的免疫测定法。在临床研究中最常使用的 2 种测定法是原始的夹心免疫发光测定法及其自动化免疫荧光后继者。此外,还开发了各种酶联免疫吸附测定法。随着 copeptin 测定法的出现,最近重新审视了尿崩症的鉴别诊断。本文的目的首先是回顾 copeptin 的生理学,其次是描述其作为血管加压素依赖性液体紊乱(主要是尿崩症,但也包括高钠血症和低钠血症)鉴别诊断标志物的用途。此外,我们强调了 copeptin 作为其他急性和慢性疾病预后标志物的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5f/9113794/44738cae676e/dgac070f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5f/9113794/ed577314aa9a/dgac070f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5f/9113794/df9988ae4cb8/dgac070f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5f/9113794/44738cae676e/dgac070f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5f/9113794/ed577314aa9a/dgac070f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5f/9113794/df9988ae4cb8/dgac070f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5f/9113794/44738cae676e/dgac070f0003.jpg

相似文献

1
Approach to the Patient: "Utility of the Copeptin Assay".患者处理:“ copeptin 检测的效用”。
J Clin Endocrinol Metab. 2022 May 17;107(6):1727-1738. doi: 10.1210/clinem/dgac070.
2
Vasopressin and Copeptin in health and disease.血管加压素和 copeptin 在健康和疾病中的作用。
Rev Endocr Metab Disord. 2019 Sep;20(3):283-294. doi: 10.1007/s11154-019-09509-9.
3
Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis. copeptin 及其在尿崩症和抗利尿激素不适当分泌综合征诊断中的作用。
Clin Endocrinol (Oxf). 2019 Jul;91(1):22-32. doi: 10.1111/cen.13991. Epub 2019 May 8.
4
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications. copeptin作为精氨酸加压素的替代标志物:分析见解、当前应用及新兴用途
Crit Rev Clin Lab Sci. 2025 Jan;62(1):24-44. doi: 10.1080/10408363.2024.2383899. Epub 2024 Jul 31.
5
Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia.copeptin作为评估多尿-多饮和低钠血症患者的生物标志物和诊断工具。
Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):235-47. doi: 10.1016/j.beem.2016.02.003. Epub 2016 Feb 16.
6
Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach.7个月婴儿尿崩症的快速鉴别诊断: copeptin方法。
Arch Pediatr. 2018 Jan;25(1):45-47. doi: 10.1016/j.arcped.2017.11.010. Epub 2017 Dec 11.
7
Copeptin in fluid disorders and stress. copeptin 在液体紊乱和应激中的作用。
Clin Chim Acta. 2022 Apr 1;529:46-60. doi: 10.1016/j.cca.2022.02.002. Epub 2022 Feb 7.
8
Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.copeptin 在血管加压素依赖性体液平衡紊乱诊断中的应用。
Nat Rev Endocrinol. 2016 Mar;12(3):168-76. doi: 10.1038/nrendo.2015.224. Epub 2016 Jan 22.
9
Copeptin in the differential diagnosis of hypotonic polyuria. copeptin 在低张性多尿症的鉴别诊断中的应用。
J Endocrinol Invest. 2020 Jan;43(1):21-30. doi: 10.1007/s40618-019-01087-6. Epub 2019 Jul 31.
10
Copeptin: clinical use of a new biomarker.copeptin:一种新型生物标志物的临床应用。
Trends Endocrinol Metab. 2008 Mar;19(2):43-9. doi: 10.1016/j.tem.2007.11.001.

引用本文的文献

1
Central Diabetes Insipidus in Father and Son Linked to a Rare Variant: A Case Report.父子患中枢性尿崩症与一种罕见变异有关:病例报告
Biomed Hub. 2025 Feb 7;10(1):57-63. doi: 10.1159/000543795. eCollection 2025 Jan-Dec.
2
Comparative Diagnostic Performance of Copeptin After Hypertonic Saline Infusion Versus Water Deprivation Test in Pediatric Patients with Polyuria-Polydipsia Syndrome.高渗盐水输注后copeptin与禁水试验在小儿多尿-多饮综合征患者中的比较诊断性能
Int J Mol Sci. 2025 Jun 6;26(12):5449. doi: 10.3390/ijms26125449.
3
The changing landscape in the evaluation of hypotonic polyuria in children and adolescents: the role of the new copeptin stimulation tests.

本文引用的文献

1
A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.一项 GLP-1 受体激动剂度拉鲁肽治疗原发性多饮症的随机对照试验。
J Clin Invest. 2021 Oct 15;131(20). doi: 10.1172/JCI151800.
2
Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome.不同 copeptin 检测方法在多尿多饮综合征鉴别诊断中的有效性。
Sci Rep. 2021 May 12;11(1):10104. doi: 10.1038/s41598-021-89505-9.
3
Vasopressin and copeptin release during sepsis and septic shock.脓毒症和脓毒性休克期间血管加压素和 copeptin 的释放
儿童和青少年低渗性多尿评估的变化态势:新型 copeptin 刺激试验的作用
J Pediatr Endocrinol Metab. 2025 May 23. doi: 10.1515/jpem-2025-0046.
4
Arginine vasopressin and copeptin: comparative review and perspective in veterinary medicine.精氨酸加压素与 copeptin:兽医学中的比较综述与展望
Front Vet Sci. 2025 Mar 14;12:1528008. doi: 10.3389/fvets.2025.1528008. eCollection 2025.
5
Central and nephrogenic diabetes insipidus: updates on diagnosis and management.中枢性和肾性尿崩症:诊断与管理的最新进展
Front Endocrinol (Lausanne). 2025 Jan 8;15:1479764. doi: 10.3389/fendo.2024.1479764. eCollection 2024.
6
Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs.口服泼尼松龙可降低健康犬的血浆精氨酸加压素和血清 copeptin 浓度。
J Vet Intern Med. 2025 Jan-Feb;39(1):e17304. doi: 10.1111/jvim.17304.
7
Copeptin after pituitary surgery: is it worth measuring?垂体手术后的 copeptin:是否值得检测?
Pituitary. 2024 Oct;27(5):429-432. doi: 10.1007/s11102-024-01418-8. Epub 2024 Jul 16.
8
Serum copeptin in women with gestational diabetes mellitus: A meta-analysis.妊娠期糖尿病患者血清 copeptin 水平:一项荟萃分析。
Biomol Biomed. 2024 Mar 7;24(4):753-763. doi: 10.17305/bb.2024.10114.
9
Very elevated serum copeptin concentrations occur in a subset of healthy children in the minutes after phlebotomy.在采血后的几分钟内,一部分健康儿童的血清 copeptin 浓度会非常高。
J Pediatr Endocrinol Metab. 2023 Nov 23;37(1):8-14. doi: 10.1515/jpem-2023-0390. Print 2024 Jan 29.
10
Diagnosis and Treatment of Hereditary Central Diabetes Insipidus in a Swiss Family With a Mutation in the Gene.一个瑞士家族中因该基因突变导致的遗传性中枢性尿崩症的诊断与治疗
JCEM Case Rep. 2022 Dec 3;1(1):luac023. doi: 10.1210/jcemcr/luac023. eCollection 2023 Jan.
Peptides. 2021 Feb;136:170437. doi: 10.1016/j.peptides.2020.170437. Epub 2020 Nov 9.
4
Excess Mortality Among Hospitalized Patients With Hypopituitarism-A Population-Based, Matched-Cohort Study.住院的垂体功能减退症患者的超额死亡率:一项基于人群的匹配队列研究。
J Clin Endocrinol Metab. 2020 Nov 1;105(11). doi: 10.1210/clinem/dgaa517.
5
Copeptin - a new diagnostic and prognostic biomarker in neurological and cardiovascular diseases.copeptin——神经和心血管疾病中的一种新型诊断和预后生物标志物。
Neuro Endocrinol Lett. 2019 Dec;40(5):207-214.
6
Copeptin is not useful as a marker of malignant disease in the syndrome of inappropriate antidiuresis.copeptin在抗利尿激素分泌异常综合征中作为恶性疾病的标志物并无用处。
Endocr Connect. 2020 Jan;9(1):20-27. doi: 10.1530/EC-19-0431.
7
Early Copeptin Determination Allows Prompt Diagnosis of Post-Neurosurgical Central Diabetes Insipidus.早期copeptin 测定有助于及时诊断神经外科术后中枢性尿崩症。
Neuroendocrinology. 2020;110(6):525-534. doi: 10.1159/000503145. Epub 2019 Sep 5.
8
Diabetes insipidus.尿崩症。
Nat Rev Dis Primers. 2019 Aug 8;5(1):54. doi: 10.1038/s41572-019-0103-2.
9
Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study.精氨酸刺激 copeptin 测量在尿崩症鉴别诊断中的作用:一项前瞻性诊断研究。
Lancet. 2019 Aug 17;394(10198):587-595. doi: 10.1016/S0140-6736(19)31255-3. Epub 2019 Jul 11.
10
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.血浆 copeptin 水平可预测常染色体显性多囊肾病的疾病进展和托伐普坦疗效。
Kidney Int. 2019 Jul;96(1):159-169. doi: 10.1016/j.kint.2018.11.044. Epub 2019 Mar 9.